Stocks
NervGen Pharma Prices $60 Million Public Offering
NervGen Pharma Corp. has priced a public offering of common shares and warrants, raising $60 million to advance its neuroreparative therapeutics.

NervGen Pharma Corp. has priced a public offering of common shares and warrants, raising $60 million to advance its neuroreparative therapeutics.

Liberty Defense Holdings Ltd. has priced its U.S. initial public offering, selling 3,673,638 common shares at $4.50 each. The offering is expected...